Compositions for the therapeutic use of an atonal-associated sequence for deafness, osteoarthritis, and abnormal cell proliferation
CA 2823479 C · Owner: Baylor College Of Medicine · Inventors: Birmingham, Nessan; Bellen, Hugo; Ben-Arie, Nissim
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Compositions and methods are disclosed for the therapeutic use of an atonal-associated nucleic acid or amino acid sequence. Also an animal heterozygous for an atonal-associated gene inactivation is also disclosed having at least one atonal-associated nucleic acid sequence replaced by insertion of a heterologous nucleic acid sequence used to detect expression driven by an atonal-associated promoter sequence wherein the inactivation of the atonal-associated nucleic acid sequence prevents expression of the atonal-associated nucleic acid.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed June 1, 2000 and granted September 15, 2015. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended June 1, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by June 1, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.